Bulletin N° 698
Subject: GLOBAL CLASS
STRUGGLE IN SPRING 2016 (ANALYTICAL THOUGHT vs. DIALECTICAL THINKING).
21 May 2016
Grenoble, France
Dear
Colleagues and Friends of CEIMSA,
Corporate
state capitalism is upon us, and the various modes of social control are quite
evident to specific populations inhabiting the different pockets of this
worn-out system. I recently directed some graduate-student research on US
policy in Haiti, and the 1967 movie The Comedians, based
on the award-winning
1966 Graham Greene novel by the same name, served to dramatize
the phenomenon of the “slave mentality” and how it was constructed in the
society at large. There is no better description of this in contemporary
American society than in Mark Ames’ remarkable book, Going Postal, in which
he observes:
… even
when people are completely aware of their misery and sense of injustice,
spouses suffer and their marriages fall
anonymous grumblings.(p.108)
The
incredible accumulation of wealth and political power today in the hands of a smaller
and smaller number of figures around the world, plus the amazing technology
this small class of rulers now has at their disposal, is nothing less than awesome.
Class struggle in this contemporary context is by no means an automatic
response to class domination. Reaching into human cognitive abilities, corporate
capitalist interests are proscriptive, not descriptive; they direct our
attention away from our real class-conscious needs for decisive action and
place us instead on a path to our own destruction by providing us with an acceptable modus vivendi
with which we can rationalize our passive “go along and get along” strategy for
living . . . until the end.
The
14 items below suggest willful alternatives to the obeisant life style
that corporate society offers us. The objective of this selection is to provoke
thought, to encourage CEIMSA readers to ask the question: Are you doing what
you really want to do;
is it really necessary to continue in the direction you are now
being moved?
Francis Feeley
Professor of American
Studies
University of Grenoble-3
Director of Research
University of
Paris-Nanterre
Center for the Advanced
Study of American Institutions and Social Movements
The University of
California-San Diego
a.
Fight
Club
This film depicts the alienation of
a ticking-time-bomb insomniac and a slippery soap salesman channelling primal male
aggression into a shocking new form of therapy. Their concept catches on, with
underground "fight clubs" forming in every town, until an eccentric
gets in the way and ignites an out-of-control spiral toward oblivion.
https://genvideos.org/watch?v=Fight_Club_1999#video=HfIAV4JSOs4ipnkGcEaklUacvtRi4AGPmdzh1qVL7Gs
or
http://niter.co/all/movies/1192709-fight-club
Release:
1999 /
Director: David Fincher
Adapted from: Fight Club
Screenplay: Jim Uhls
Story by: Chuck Palahniuk
+
Falling Down
|
http://putlocker.is/watch-falling-down-online-free-putlocker.html Release:
1993 / Falling Down |
|
Genre:
Crime | Drama | Thriller |
|
Director:
Joel Schumacher |
|
Stars:
Michael Douglas, Robert Duvall, Barbara Hershey |
|
Synopsis:
William (D-FENS) just wants to get home to see his daughter on her birthday.
Unfortunately, nothing seems to be going right for him. First there's the
traffic jam, then the unhelpful Korean shopkeeper who "doesn't give
change". D-FENS begins to crack and starts to fight back against the every day "injustices" he encounters on his
journey home. The film has a story running in parallel about a desk-bound cop
who is about to retire. He's retiring for his wife's sake, and obviously
isn't happy about it. The cop tracks down D-FENS and in the final scene..... |
===========
b.
Zionism Begins to Unravel
http://www.informationclearinghouse.info/article44708.htm
by Lawrence Davidson
===========
c.
Sanders and Class Struggle
in the Democratic Party
http://therealnews.com/t2/index.php?option=com_content&task=view&id=31&Itemid=74&jumival=16363
===========
d.
Republicans Would
Rather Lose the 2016 Election
than Win with Donald Trump
http://therealnews.com/t2/index.php?option=com_content&task=view&id=31&Itemid=74&jumival=16337
Glen Ford of the Black Agenda Report says Trump's candidacy is throwing both
Democratic and Republican parties into crisis
===========
e.
On
the Side of the Road
http://therealnews.com/t2/index.php?option=com_content&task=view&id=31&Itemid=74&jumival=16330
The acclaimed film by Lia Tarachansky
about those who fought to erase Palestine and created an Israeli landscape of
denial
===========
f.
As Palestinians Mourn Their Nakba, the UK Must Acknowledge its Responsibility
by Ahmad Samih
Khalidi
Today marks the 68th anniversary of the Palestinian
Nakba (catastrophe): the Palestinians’ dispossession
and
the loss of their homeland.
===========
g.
From: Edward S Herman
Subject: The Israel lobby and the European Union
Francis,
a very valuable study.
ed herman
The
Israel lobby and the European Union
http://europalforum.org.uk/en/uploads/upload_center/kH1JNtI1qm1q.pdf
New detailed report shows
how racist Zionists work at high levels in Brussels and beyond. 700 footnotes/references.
Organizations fund the European "Friends of Israel" and other
pro-Israel enterprises like settlements, Birthright tours, etc. David Horowitz
Foundation,
Henry Jackson
Foundation along with the Adelmans, etc.
===========
h.
The
USA: How To Make Them Give A Damn?
http://journal-neo.org/2016/05/12/the-usa-how-to-make-them-give-a-damn/
by Christopher Black
It is clear that the “terrorists” the world is facing
are U.S. proxy forces attempting to destabilise the
word for American interests.
===========
i.
From: "Jim O'Brien" <jimobrien48@gmail.com>
Subject: [haw-info] HAW Notes 5/18/16: Links to recent articles of
interest
Links to Recent Articles
of Interest
By Alexis Dudden, LobeLog, posted
May 17
The author teaches
history at the University of Connecticut.
"Explainer: What Is the 100-Year-Old Sykes-Picot
Agreement?"
By Stephen Pascoe, The
Conversation, posted May 12
The author is a PhD
candidate in history at La Trobe University.
"The Costs of Violence:
Masters of Mankind (Part 2)"
By Noam
Chomsky, TomDispatch.com, posted May 10
"American Power under
Challenge: Masters of Mankind (Part 1)"
By Noam
Chomsky, TomDispatch.com, posted May 8
"American Imperium:
Untangling Truth and Fiction in an Age of Perpetual War"
By Andrew J. Bacevich, Harper's Magazine, May issue
The author is a
professor emeritus of history and international relations at Boston University.
"Three Centuries of US
Writings Against Wars"
By David Swanson, Let's
Try Democracy blog, posted May 4
"How
the Curse of Sykes-Picot Still Haunts the Middle East"
By Robin Wright, The
New Yorker, posted April 30
"Trump's
Foreign Policy is Just GOP Boilerplate, Only More
Confused"
By Juan Cole, Informed
Comment blog, posted April 28
Suggestions for these occasional lists can be
sent to jimobrien48@gmail.com.
Thanks to an anonymous reader for suggesting some of the articles included in
the above list.
===========
j.
Intellectual Property Health Digest, Vol. 73, Issue 10
May 14, 2016
Today's Topics:
1. Re: India - Cabinet approves National Intellectual Property Rights Policy (Mohga Kamal-Yanni)
2. U.S.'s Newest IP Gunship Diplomacy in Columbia - Same Threats
with Dollars not Bullets (Baker, Brook)
3. TTIP dead?? (George Carter)
4. Re: India - Cabinet approves National Intellectual Property Rights Policy (Michael H
Davis)
----------------------------------------------------------------------
Message: 1
From: Mohga Kamal-Yanni
<mkamalyanni@Oxfam.org.uk>
To: IP-health <ip-health@lists.keionline.org>
Subject: Re: [Ip-health] India - Cabinet approves
National Intellectual Property Rights Policy
Link to India's new IP policy
http://dipp.gov.in/English/Schemes/Intellectual_Property_Rights/National_IPR_Policy_12.05.2016.pdf
Statement -Press
Information Bureau, Government of India- Cabinet approves National
Intellectual Property Rights Policy (http://pib.nic.in/newsite/erelease.aspx).
The Union Cabinet
yesterday approved the National Intellectual Property
Rights (IPR) Policy that will lay the future roadmap for intellectual
property in India. The Policy recognises the
abundance of creative and
innovative energies that flow in India, and the need to tap into and
channelise these energies towards a better and
brighter future for all.
The National IPR Policy
is a vision document that aims to create and
exploit synergies between all forms of intellectual property (IP),
concerned statutes and agencies. It sets in place an institutional
mechanism for implementation, monitoring and review. It aims to
incorporate and adapt global best practices to the Indian scenario. This
policy shall weave in the strengths of the Government, research and
development organizations, educational institutions, corporate entities
including MSMEs, start-ups and other stakeholders in the creation of an
innovation-conducive environment, which stimulates creativity and
innovation across sectors, as also facilitates a stable, transparent and
service-oriented IPR administration in the country.
The Policy recognizes
that India has a well-established TRIPS-compliant
legislative, administrative and judicial framework to safeguard IPRs,
which meets its international obligations while utilizing the
flexibilities provided in the international regime to address its
developmental concerns. It reiterates India?s commitment to the Doha
Development Agenda and the TRIPS agreement.
While IPRs are becoming
increasingly important in the global arena, there
is a need to increase awareness on IPRs in India, be it regarding the
IPRs
owned by oneself or respect for others? IPRs. The importance of IPRs as a
marketable financial asset and economic tool also needs to be recognised.
For this, domestic IP filings, as also commercialization of patents
granted, need to increase. Innovation and sub-optimal spending on R&D
too
are issues to be addressed.
The broad contours of
the National IPR Policy are as follows:
Vision Statement: An
India where creativity and innovation are stimulated
by Intellectual Property for the benefit of all; an India where
intellectual property promotes advancement in science and technology,
arts
and culture, traditional knowledge and biodiversity resources; an India
where knowledge is the main driver of development, and knowledge owned is
transformed into knowledge shared.
Mission Statement:
Stimulate a dynamic, vibrant and balanced intellectual property rights
system in India to:
o foster creativity and innovation
and thereby, promote entrepreneurship
and enhance socio-economic and cultural development, and
o focus on enhancing access to
healthcare, food security and
environmental protection, among other sectors of vital social, economic
and technological importance.
Objectives:
The Policy lays down the
following seven objectives:
i. IPR Awareness: Outreach and Promotion - To
create public awareness
about the economic, social and cultural benefits of IPRs
among all sections of society.
ii. Generation of IPRs -
To stimulate the generation of IPRs.
iii. Legal and
Legislative Framework - To have strong and effective IPR
laws, which balance the interests of rights owners with
larger public interest.
iv. Administration and
Management - To modernize and strengthen
service-oriented IPR administration.
v. Commercialization of
IPRs - Get value for IPRs through
commercialization.
vi. Enforcement and
Adjudication - To strengthen the enforcement and
adjudicatory mechanisms for combating IPR infringements.
vii. Human Capital
Development - To strengthen and expand human resources,
institutions and capacities for teaching, training,
research and skill building in IPRs.
These objectives are
sought to be achieved through detailed action points.
The action by different Ministries/ Departments shall be monitored by
DIPP
which shall be the nodal department to coordinate, guide and oversee
implementation and future development of IPRs in India.
------------------------------
Message: 2
From: "Baker, Brook" <b.baker@neu.edu>
To: IP-health <ip-health@lists.keionline.org>
Subject: [Ip-health] U.S.'s Newest IP Gunship
Diplomacy in Columbia - Same Threats with Dollars not Bullets
“U.S.'s
Newest IP Gunship Diplomacy in Columbia - Same Threats with Dollars not
Bullets”
Prof. Brook K. Baker, Senior Policy Analyst, Health GAP
May 13, 2016
It used to be that when
the U.S. wanted to exert its influence or extend the imperial power of its
businesses in Latin America, it would resort to gunships. In the old
days, the raw use of naked armed power needed little justification. In the more modern era of proxy wars, the U.S. Is more likely to send money and arms, as it has done consistently
with Columbia for its War on Drug. The latest tranche of funding
for Columbia, designed to enable peace talks - if you will a cease-fire in the
War on Drugs, is the $450 million Paz Columbia proposal before Congress.
One would think that the
rationale for a peace process in Columbia that might dampen the flow of illegal
drug to the U.S. is strong and that funding for this effort can be ring fenced
and justified on its own account. But not in the world of topsy turvy politics in
Washington where the special interests of Big Pharma
trump even priority peace initiatives. Why is Pharma
involved in Paz Columbia and why has the U.S. manned the battle stations?
Because Columbia has deigned to discuss issuing a compulsory license to
stop being robbed by a Swiss pharmaceutical company, Novartis, on the cost of a
highly effective, but grossly overpriced leukemia medicine, Gleveec.
This is how lobbying and
gunship diplomacy work in tandem on Pharma's behalf.
*
Novartis, even though a foreign company, contacts its proxy in the
U.S., the Pharmaceutical Research and Manufacturers of America. Novartis
says, "Our monopoly pricing is being threatened in Columbia, and you
should be concerned because it could happen to your membership too."
PhRMA in turn contacts the U.S. Chamber of
Commerce to line up support from other IP-intensive industry groups.
* PhRMA and Chamber of Commerce
lobbyists march with briefcases to the Office of the United States Trade
Representative for years where they have totally
captured its trade agenda (more pharma lobbyists for
the USTR than for the Food and Drug Administration). The USTR
consistently pursues stronger and longer IP monopolies and greater IP
enforcement policies even as it simultaneously threatens and pressures any
country that does not accept Big Pharma's monopoly
control. It jumps into action for Novartis.
* PhRMA and the Chamber of Congress
also contribute campaign funds to key Members of Congress, most especially
chairs of key committees, like Orin Hatch who heads up the Senate Finance
Committee. When Columbia threatens to issue a compulsory license to allow
generic versions of Novartis's medicines, PhRMA
lobbyists go straight to the top and ask Senator Hatch to appoint one of his
key staffers to put pressure on Columbia.
* The USTR and the Congressional staffer, in this case Everett
Eissenstat, both goes to the Columbia's embassy in
Washington and make identical threats: (1) our unhappy PhRMA and Chamber of Congress will threaten Paz Columbia
funding if Columbia does not drop its compulsory licensing threat and (2) trade
retaliation threats from the U.S. will escalate and you may be blocked from
entering other regional trade deals with the U.S., including the Trans-Pacific
Partnership Agreement.
* The Columbia embassy in Washington contacts Columbia
officials in Bogota, warning that Columbia should stand down from its
threatened compulsory license and continue to allow Novartis to charge whatever
it wants.
* (In the future, Senator Hatch gets more PhRMA
donations and members of his staff and former USTR officials become highly paid
industry lobbyists.)
In this world of Big Pharma acting as the puppeteer and ordering U.S. officials
to do its bidding with escalating threats of economic and trade reprisals, it
doesn't matter that it is completely lawful under international law, Columbia's
trade agreement with the U.S., and its own national law that Columbia might
issue a compulsory license. That right is enshrined in the WTO Agreement
on Trade Related Aspects of Intellectual Property Rights, in the 2001 Doha
Declaration on the TRIPS Agreement and Public Health, and in the US-Columbia
Trade Promotion Authority Agreement. The argument of the USTR and Mr. Eissenstat that there needs to be special justifications
for issuing a compulsory license is totally false - and they know it.
These backdoor pressures
and economic threats are just as dangerous as gunships sitting in a harbor.
And they can be just a deadly - cannon balls blow up people, but lack of
access to affordable life-saving medicines commits people with cancer to needlessly
short lives of suffering and misery as well.
------------------------------
Message: 3
From: George Carter <fiar@verizon.net>
To: ip-health <ip-health@lists.keionline.org>
Subject: [Ip-health] TTIP dead??
Hallelujah!
But I never discount the capacity of industry to trump democracy, let alone
human life and the planet’s ecosystems to assure more PROFITS.
https://www.theguardian.com/business/2016/may/03/ttip-has-been-kicked-into-the-long-grass-for-a-very-long-time?CMP=share_btn_tw
George
M. Carter
------------------------------
Message: 4
From: Michael H Davis <m.davis@csuohio.edu>
To: IP-health <ip-health@lists.keionline.org>
Subject: [Ip-health] India - Cabinet approves
National Intellectual Property Rights
Policy.
India should first
survey the literature and decide whether ip actually
produces any social good. It won't find any good studies that say so. So why
pass this, why increase ip, and why increase
enforcement of a socially harmful phenomenon?
Link to India's new IP policy
http://dipp.gov.in/English/Schemes/Intellectual_Property_Rights/National_IPR_Policy_12.05.2016.pdf
Statement - Press Information Bureau, Government of India- Cabinet approves
National Intellectual Property Rights Policy (http://pib.nic.in/newsite/erelease.aspx)
The Union Cabinet
yesterday approved the National Intellectual Property
Rights (IPR) Policy that will lay the future roadmap for intellectual
property in India. The Policy recognises the
abundance of creative and
innovative energies that flow in India, and the need to tap into and
channelise these energies towards a better and
brighter future for all.
The National IPR Policy
is a vision document that aims to create and
exploit synergies between all forms of intellectual property (IP),
concerned statutes and agencies. It sets in place an institutional
mechanism for implementation, monitoring and review. It aims to
incorporate and adapt global best practices to the Indian scenario. This
policy shall weave in the strengths of the Government, research and
development organizations, educational institutions, corporate entities
including MSMEs, start-ups and other stakeholders in the creation of an
innovation-conducive environment, which stimulates creativity and
innovation across sectors, as also facilitates a stable, transparent and
service-oriented IPR administration in the country.
The Policy recognizes
that India has a well-established TRIPS-compliant
legislative, administrative and judicial framework to safeguard IPRs,
which meets its international obligations while utilizing the
flexibilities provided in the international regime to address its
developmental concerns. It reiterates India?s commitment to the Doha
Development Agenda and the TRIPS agreement.
While IPRs are becoming
increasingly important in the global arena, there
is a need to increase awareness on IPRs in India, be it regarding the IPRs
owned by oneself or respect for others? IPRs. The importance of IPRs as a
marketable financial asset and economic tool also needs to be recognised.
For this, domestic IP filings, as also commercialization of patents
granted, need to increase. Innovation and sub-optimal spending on R&D too
are issues to be addressed.
The broad contours of
the National IPR Policy are as follows:
Vision Statement: An
India where creativity and innovation are stimulated
by Intellectual Property for the benefit of all; an India where
intellectual property promotes advancement in science and technology, arts
and culture, traditional knowledge and biodiversity resources; an India
where knowledge is the main driver of development, and knowledge owned is
transformed into knowledge shared.
Mission Statement:
Stimulate a dynamic, vibrant and balanced intellectual property rights
system in India to:
o foster creativity and innovation
and thereby, promote entrepreneurship
and enhance socio-economic and cultural development, and
o focus on enhancing access to
healthcare, food security and
environmental protection, among other sectors of vital social, economic
and technological importance.
Objectives:
The Policy lays down the
following seven objectives:
i. IPR Awareness: Outreach and Promotion - To
create public awareness
about the economic, social and cultural benefits of IPRs
among all sections of society.
ii. Generation of IPRs -
To stimulate the generation of IPRs.
iii. Legal and
Legislative Framework - To have strong and effective IPR
laws, which balance the interests of rights owners with
larger public interest.
iv. Administration and
Management - To modernize and strengthen
service-oriented IPR administration.
v. Commercialization of
IPRs - Get value for IPRs through
commercialization.
vi. Enforcement and
Adjudication - To strengthen the enforcement and
adjudicatory mechanisms for combating IPR infringements.
vii. Human Capital
Development - To strengthen and expand human resources,
institutions and capacities for teaching, training,
research and skill building in IPRs.
These objectives are
sought to be achieved through detailed action points.
The action by different Ministries/ Departments shall be monitored by DIPP
which shall be the nodal department to coordinate, guide and oversee
implementation and future development of IPRs in India.
===========
k.
Putin: The U.S.
Could Be Conspiring Against Us
Video
http://www.informationclearinghouse.info/article44655.htm
President Putin believes in the active theory of 'containment' of Russia, when it
comes to Western foreign policy. Washington is a Printing Machine of Fiat
Money.
===========
l.
Dilma Out: Brazilian Plutocracy Sets 54
Million Votes On Fire
https://www.rt.com/op-edge/342821-brazil-dilma-rousseff-impeachment/
by Pepe
Escobar
===========
m.
From: Edward S Herman
Subject: The Coming Democratic Crackup
One of the best sources of
information on current events.
|
===========
n.
Intellectual Property Health Digest, Vol. 73, Issue 11
May
16, 2016
Today's Topics:
1. Sign-on for Colombia until 3pm hour Bogota Monday (Peter Maybarduk)
2. Re: India - Cabinet approves National Intellectual
Property Rights Policy (George Carter)
3. Blackmail -What is better: Silver gringos or the lives
of thousands of people? (Jamie Love)
----------------------------------------------------------------------
Message: 1
Date: Mon, 16 May 2016 02:44:16 +0000
From: Peter Maybarduk <pmaybarduk@citizen.org>
Subject: [Ip-health] Sign-on for Colombia until 3pm
hour Bogota Monday
Colleagues,
We will accept signatures in support of this letter until 3pm Bogota / 10pm
Geneva time, Monday (that's probably today for most of you reading). We are up
to 105 signatories so far.
Thank you, -Peter
---
Mr. President
JUAN MANUEL SANTOS
President of the Republic of Colombia
SUBJECT: Colombia’s Right to Issue a Compulsory License for the Cancer Medicine
Imatinib
Dear President Santos,
We are lawyers, academics and other experts specializing in fields including
intellectual property, trade and health, writing to affirm that international
law and policy support Colombia?s right to issue compulsory
licenses on patents in order to promote public interests including access to
affordable medicines.?
Colombia’s Ministry of Health and Social Protection has proposed to declare
access to the cancer medicine imatinib under
competitive conditions to be a matter of public interest. A public interest
declaration should lead to the grant of a compulsory license on a patent held
by Novartis, facilitating generic competition and reducing prices. We encourage
your administration, the Ministry of Health and the Superintendency
of Industry and Trade to proceed with the public interest declaration.
Recent media reports suggest that staff for the U.S. Senate Finance Committee
and potentially representatives of the U.S. government may have communicated
incorrect beliefs about compulsory licensing to their Colombian counterparts.[1] If the reports are accurate, those officials have acted
inappropriately, and contravened U.S. government policy, which supports trading
partners’ rights to issue compulsory licenses.? We condemn any pressure levied
against Colombia for its use of lawful policies such as compulsory licensing to
promote public health.
Article 31 of the World Trade Organization’s Agreement on Trade-Related Aspects
of Intellectual Property (WTO?s TRIPS) permits all WTO
members, including Colombia, to issue compulsory licenses at any time on
grounds of their choosing[2]. The only compensation due to patent-holders in
instances of compulsory licensing is a reasonable royalty, which governments
may determine at their discretion[3].
The WTO?s Declaration on the TRIPS Agreement and
Public Health affirms this interpretation of Article 31 and its importance to
health.[4] The ?Doha Declaration? explicitly
recognizes the impact of intellectual property on medicine prices and states
that countries? patent obligations under WTO rules
?should be interpreted and implemented in a manner supportive of WTO members’
right to protect public health and, in particular, to promote access to
medicines for all.?
The issuance of a compulsory license on imatinib is
entirely consistent with the terms of trade and investment agreements to which
Colombia is a party.[5] The U.S. ?May 10th Agreement? of 2007, for example, expressly incorporated certain public
health safeguards in the U.S.-Colombia Trade Promotion Agreement and preserved
Colombia’s right to issue licenses for patented inventions.
High prices for any important medicine impose a burden on the public health
system responsible for providing it, and lead to the rationing of treatment and
other health services. When a pharmaceutical company uses a patent to exclude
competition, it can charge much higher prices.??
A recent report by Colombia?s Ministry of Health and
Social Protection specifies considerable predicted cost savings through a
compulsory license for imatinib.[6] The report of the
ministry?s Technical Committee for the Public
Interest Declaration states:
"...The impact on health system financing of only a single manufacturer
supplying imatinib in the market is important.
Additionally, prices of Glivec, despite being subject
to controls, are still very high compared with generics, which have been
progressively leaving the market with the grant of the patent. Direct price controls ? will never match the
results achieved by competition in the market. Without a doubt, the best way to
reduce prices is competition."
Novartis has rejected the Colombian government’s offer to negotiate a price
reduction for imatinib.
Issuing a compulsory license does not expropriate the property rights of the
patent holder. Rather, the right of a government to authorize other uses of a
patented invention is embedded and reserved in the grant of a patent.
Furthermore, a license does not prevent the patent holder from continuing to
sell its product, prohibit non-licensed uses of the invention, or prohibit
non-licensed parties from using the invention.??
We hope this letter will support Colombia?s
ongoing efforts to increase access to affordable medicines and put to rest any
concerns regarding the international legitimacy of compulsory licensing.?
Compulsory licensing is a key tool for protecting the financial stability of
health systems and ensuring access to medicines and health services for all.
Sincerely,
[1] See http://www.elespectador.com/noticias/salud/presiones-de-eeuu-colombia-no-regule-el-precio-del-imat-articulo-631535
and http://keionline.org/node/2504.
[1] Available at:? www.wto.org/spanish/docs_s/legal_s/27-trips_04c_s.htm. See
also World Trade Organization, ?TRIPS and Health:
Frequently Asked Questions,? available at: https://www.wto.org/english/tratop_e/trips_e/public_health_faq_e.htm.
[1] Id. Art 31 (h)
[1] World Trade Organization Declaration on the TRIPS Agreement and Public
Health, adopted 14 November 2001, available at:? https://www.wto.org/english/thewto_e/minist_e/min01_e/mindecl_trips_e.htm.
[1] E.g. Colombia-USA Trade Promotion Agreement, Article 10.7: Expropriation
and Indemnification, available at: http://www.sice.oas.org/Trade/COL_USA_TPA_s/Text_s.asp#a107;? Colombia-EFTA States Free Trade Agreement, Article 6.2,
Basic Principles, available at: http://www.efta.int/media/documents/legal-texts/free-trade-relations/colombia/EFTA-Colombia%20Free%20Trade%20Agreement%20SP.pdf.
[1] Informe sobre la recomendacio?n
al Ministro de Salud y Proteccio?n Social en relacio?n
con la solicitud de declaratoria
de intere?s pu?blico del imatinib con fines de
licencia obligatoria. Ministerio
de Salud y Proteccio?n Social, Comite? Te?cnico Declaratoria de intere?s pu?blico.Bogota?, Colombia 24 de febrero de 2016 . Available at: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/MET/informecomiteimatinib-22022016-vf.pdf.
------------------------------
Message: 2
Date: Sat, 14 May 2016 11:48:25 -0400
From: George Carter <fiar@verizon.net>
Subject: Re: [Ip-health] India - Cabinet approves
National Intellectual Property Rights Policy.
India should first survey the literature and decide whether it actually
produces any social good. It won't find any good studies that say so. So why
pass this, why increase ip, and why increase
enforcement of a socially harmful phenomenon?
Money. Threats by the belligerent
bastard, USTR Froman and the government. Modi?s obsequious greed; he
probably thinks he can play it both ways and make more money, even while
screwing his own country’s generics industry.
Utter indifference to the sick because power and money, kowtowing and cruelty
are what define our species as we head rapidly toward self-inflicted
extinction.
George M. Carter
------------------------------
Message: 3
Date: Mon, 16 May 2016 13:08:32 -0400
From: Jamie Love <james.love@keionline.org>
Subject: [Ip-health] Blackmail -What is better:
Silver gringos or the lives of thousands of people?
This is how Google translates today's El Tiempo op-ed
by Paola Ochoa
http://www.eltiempo.com/opinion/columnistas/chantaje-paola-ochoa-columnista-el-tiempo/16593982
Blackmail -What is
better: Silver gringos or the lives of thousands of people?
by Paola Ochoa
May 16, 2016
It is the universal rule of Uncle Sam: no free lunch. While Kerry met with
Santos in London to express their support for the peace process in the US
Congress blackmailing our country vulgar: o the price of the main drug
against cancer or 450 million dollars left still Colombia gringa
helps run
the risk of evaporating.
A threat that came to light last Thursday, when 'The Huffington Post'
leaked an internal memo from the Colombian Foreign Ministry: "Given the
direct relationship between a significant group of congressmen with the
pharmaceutical industry in the US. UU., Glivec case is likely to escalate
to the point of creating a downside to the approval of the resources of the
new initiative called Peace Colombia ". (See memo).
It is not any bullshit. Glivec is the main drug to
fight leukemia in
Colombia. The proposal by Health Minister Alejandro Gaviria, is to lower
its price in half. And the reason is elementary: the price is sky and
bleeding the national health system. But the multinational Novartis refuses
to lower the price of retrechera way and therefore
went to make 'lobby' in
the gringo Congress historically given to the interests of the
pharmaceutical.
How will the so huge power of this industry that the three candidates in
the run for the White House all agree on this issue. Hillary Clinton,
Donald Trump and Bernie Sanders have spoken in this campaign of brutality
and greed of the pharmaceutical industry and how it has taken over the US
Congress. That and the arms industry are the two great 'lobbyists' in
Washington.
[Illustration: Juan Felipe Sanmiguel.]
Colombia already has personally suffered in the past. This happened in the
previous decade, when the US Congress approved the extension of tariff
preferences United States to Colombian products. Blackmail was igualito to
now: or we gave more gabelas pharmaceutical
multinationals, or no more
ATPDEA for Colombia. The same happened with the FTA negotiations: o
endurec?amos rules on
protection of drug patents -in detriment of generics
drugs or had not Free Trade Agreement. Nice kneepads that we have!
America has always made the same cuentico: that of
intellectual property
and the alleged drug patent protection. But I wonder if there are more
important 450 million dollars Paz Colombia that the lives of thousands of
Colombians who die each year from leukemia inability to access the high
price of primary drug for such a tragedy.
There are painted the gringos. Always giving us silver on the
one hand to
charge more by the other. So it has been with the disinterested 'help'
Plan
Colombia: 10,000 million dollars we pay them with the purchase of tons of
weapons, hundreds of planes and helicopters to US companies. Not to mention
the dozens of telephone equipment and interceptions, millions of dollars in
herbicides for spraying blessed and a long list of advice and consultancy
with American cooperation agencies.
No free lunch, says Uncle Sam. But to me it seems absurd that in Colombia
we prefer to change a few dollars for the lives of millions of people. Life
is priceless.
PAOLA OCHOA
@PaolaOchoaAmaya
--
James Love. Knowledge Ecology International
http://www.keionline.org/donate.html
KEI DC tel: +1.202.332.2670,
US Mobile: +1.202.361.3040, Geneva Mobile:
+41.76.413.6584, twitter.com/jamie_love
End of Ip-health Digest, Vol
73, Issue 11
*****************************************